Michael Recht, M.D., Ph.D., M.B.A.

  • Professor of Pediatrics, Division of Hematology and Oncology, School of Medicine
  • Chief Science Officer, American Thrombosis and Hemostasis Network


Dr. Recht, a pediatric hematologist, see patients through the Hemophilia Center at OHSU. He specializes in the care of children, adolescents and young adults with bleeding and clotting disorders. In addition, Dr. Recht serves as the Chief Science Officer of the American Thrombosis and Hemostasis Network (ATHN), a nonprofit organization dedicated to improving the lives of people affected by bleeding and clotting disorders. As ATHN's Chief Science Officer, Dr. Recht works at the strategic and policy level to define, develop and implement ATHN's science and research strategy. 

From 2007-2020, Dr. Recht was the director of the Hemophilia Center at OHSU as well as the director of the Mountain States Hemophilia Network, the federally-suppported collaboration of Hemophilia Treatment Centers in the western United States. Prior to joining OHSU, Dr. Recht was the founding medical director of the Hemophilia Center at Phoenix Children’s Hospital. 

Dr. Recht has actively participated in over 100 clinical research trials testing new treatments for children and adults with bleeding and clotting disorders, including being a leader in research involving gene therapy for hemophilia. 

After growing up in Milwaukee, Wisconsin, Dr. Recht received his B.S. in psychology, his Ph.D. in human cancer biology, and his M.D., all at the University of Wisconsin. He completed his residency and fellowship training at Yale University School of Medicine. In his free time, Dr. Recht enjoys spending time with his wife, two young adult daughters and three dogs. He is an avid skier. During the few months when snow doesn't cover Mt. Hood, he can be found any coast or shore.


  • B.S., 1987, University of Wisconsin
  • Ph.D., 1990, University of Wisconsin
  • M.D., 1992, University of Wisconsin
  • M.B.A., 2016, Oregon Health & Science University/ Portland State University
  • Residency:

    • Pediatrics, Yale New Haven Hospital, Yale University, 1995
  • Fellowship:

    • Fellowship in pediatric hematology-oncology, Yale University School of Medicine, 1998
  • Certifications:

    • American Board of Pediatrics, 1995, 2002

Memberships and associations

  • American Thrombosis and Hemostasis Network
  • Foundation for Women and Girls with Blood Disorders
  • American Society of Hematology
  • Hemophilia and Thrombosis Research Society
  • International Society on Thrombosis and Hemostasis
  • American Society of Pediatric Hematology-Oncology
  • National Hemophilia Foundation

Areas of interest

  • Care of children, adolescents, and young adults with bleeding and clotting disorders
  • Long term studies examining the safety and effectiveness of current and novel therapies for bleeding and clotting disorders
  • Gene therapy for hemophilia


Selected publications

  • The critical need for postmarketing surveillance in gene therapy for?haemophilia. Konkle BA, Recht M, Hilger A, Marks P. Haemophilia. 2020 Jun 3. Online ahead of print. PMID:?32495492
  • Emicizumab in?Hemophilia?A. Buckner TW, Watson C, Recht M.N Engl J Med. 2020 Feb 20;382(8):785-786. PMID:?32074441
  • The national blueprint for 21st century data and specimen collection and observational cohort studies: NHLBI State of the Science Workshop on factor VIII inhibitors. Konkle BA, Recht M; members of Working Group 2, the NHLBI State of the Science Workshop on factor VIII inhibitors: Generating a national blueprint for future research. Haemophilia. 2019 Jul;25(4):590-594. PMID:?31329362


  • {{ pub.journalAssociation.journal.name.text[0].value }}
    1. {{ person.name.firstName }} {{ person.name.lastName }}